Alteration of liver N-glycome in patients with hepatocellular carcinoma


Purpose: Alteration of liver function during pro- gression of hepatocellular carcinoma (HCC) and cirrhosis affects the serum glycoprotein pattern. In this study, the changes in the N-glycome in liver tis- sue from patients with hepatocellular carcinoma and cirrhosis caused by hepatitis B virus infection were investigated to find out the relationship between this maker and liver disease. Methods: Twenty patients, 11 with cirrhosis and 9 with hepatocellular carcinoma, and 15 healthy donors were involved in this study. Liver protein N-glycans were profiled using the DSA-FACE technique developed in our laboratory. To further analyze the fucosylation status of these liver glycans Western lectin blots of total liver proteins were performed using Aspergillus oryzae lectin (AOL) as probe, which is a carbohydrate- binding protein that recognizes specifically α-1,6-fu- cosylated glycans. Results: The N-glycome of liver proteins in patients with HBV related HCC and cirrhosis was analyzed. Compared with healthy donors, the N-glycome had significantly less (p < 0.05) high mannose (M8) in both groups of patients. The total core α-1,6-fucosy-lation in total liver glycoproteins was dramatically increased during the progress of hepatocellular carcinoma and cirrhosis compared to the controls. Conclusion: These results show that fucosylation not only increases in serum proteins but also in liver tissue itself of patients with HBV related HCC and cirrhosis.

Share and Cite:

Wang, L. , Vanhooren, V. , Dewaele, S. , Liu, X. , Libert, C. , Lu, F. , Zhuang, H. and Chen, C. (2012) Alteration of liver N-glycome in patients with hepatocellular carcinoma. Open Journal of Gastroenterology, 2, 1-8. doi: 10.4236/ojgas.2012.21001.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Bruix, J., Boix, L., Sala, M. and Llovet, J.M. (2004) Fo- cus on hepatocellular carcinoma. Cancer Cell, 5, 215-219. doi:10.1016/S1535-6108(04)00058-3
[2] Liaw, Y.F. (2005) Prevention and surveillance of hepatic- tis B virus-related he-patocellular carcinoma. Seminars in Liver Disease, 25, 40-47. doi:10.1055/s-2005-915649
[3] Koike, K. (2005) Molecular basis of hepatitis C virus-as- sociated hepatocarcinogenesis: Lessons from animal mo- del studies. Clinical Gastroenterology and Hepatology, 3, S132-S135. doi:10.1016/S1542-3565(05)00700-7
[4] Aravalli, R.N., Steer, C.J. and Cressman, E.N. (2008) Mo- lecular mechanisms of hepatocellular carcinoma. Hepa- tology, 48, 2047-2063. doi:10.1002/hep.22580
[5] Dwek, R.A. (1998) Biological importance of glycosyla- tion. Developments in Biological Standardization, 96, 43- 47.
[6] Trombetta, E.S. and Parodi, A.J. (2005) Glycoprotein reglucosylation. Methods, 35, 328-337. doi:10.1016/j.ymeth.2004.10.004
[7] Liu, X.E., Desmyter, L., Gao, C.F., Laroy, W., Dewaele, S., Vanhooren, V., Wang, L., Zhuang, H., Callewaert, N., Libert, C., Contreras, R. and Chen, C. (2007) N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. He-patology, 46, 1426-1435. doi:10.1002/hep.21855
[8] Goldman, R., Ressom, H.W., Varghese, R.S., Goldman, L., Bascug, G., Loffredo, C.A., Abdel-Hamid, M., Gouda, I., Ezzat, S., Kyselova, Z., Mechref, Y. and Novotny, M.V. (2009) Detection of hepatocellular carcinoma using glycomic analysis. Clinical Cancer Research, 15, 1808- 1813. doi:10.1158/1078-0432.CCR-07-5261
[9] Chen, C., Schmilovitz-Weiss, H., Liu, X.E., Pappo, O., Halpern, M., Sulkes, J., Braun, M., Cohen, M., Barak, N., Tur-Kaspa, R., Vanhooren, V., Van Vlierberghe, H., Lib- ert, C., Contreras, R. and Ben-Ari, Z. (2009) Serum pro- tein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steato-hepatitis. Journal of Proteome Research, 8, 463-470. doi:10.1021/pr800656e
[10] Vanderschaeghe, D., Laroy, W., Sablon, E., Halfon, P., Van Hecke, A., Delanghe, J. and Calle-waert, N. (2009) GlycoFibroTest is a highly performant liver fibrosis bio- marker derived from DNA sequencer-based serum pro- tein glycomics. Molecular & Cellular Proteomics, 8, 986- 994. doi:10.1074/mcp.M800470-MCP200
[11] Vanderschaeghe, D., Laroy, W., Sablon, E., Halfon, P., Van Hecke, A., Delanghe, J. and Callewaert, N. (2004) Noninvasive diagnosis of liver cirr-hosis using DNA se- quencer-based total serum protein gly-comics. Nature Me- dicine, 10, 429-434. doi:10.1038/nm1006
[12] Vanhooren, V., Laroy, W., Libert, C. and Chen, C. (2008) N-Glycan profiling in the study of human aging. Bio- gerontology, 9, 351-356. doi:10.1007/s10522-008-9140-z
[13] Laroy, W., Contreras, R. and Callewaert, N. (2006) Gly- come mapping on DNA se-quencing equipment. Nature Protocols, 1, 397-405. doi:10.1038/nprot.2006.60
[14] Maras, M., Callewaert, N., Piens, K., Claeyssens, M., Mar- tinet, W., Dewaele, S., Contre-ras, H., Dewerte, I., Penttil?, M. and Contreras, R. (2000) Mo-lecular cloning and enzy- matic characterization of a Trichoderma reesei 1,2-alpha- D-mannosidase. Journal of Biotechnology, 77, 255-263. doi:10.1016/S0168-1656(99)00222-9
[15] Matsumura, K., Higashida, K., Ishida, H., Hata, Y., Ya- mamoto, K., Shigeta, M., Mizuno-Horikawa, Y., Wang, X., Miyoshi, E., Gu, J. and Taniguchi, N. (2007) Carbo- hydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: A novel probe for core fucose. The Journal of Biological Chemistry, 282, 15700-15708. doi:10.1074/jbc.M701195200
[16] Giannini, E., Risso, D. and Testa, R. (2001) Transport- ability and reproducibility of the AST/ALT ratio in chro- nic hepatitis C patients. The American Journal of Gas- troenterology, 96, 918-919. doi:10.1111/j.1572-0241.2001.03646.x
[17] Silva, I.S., Ferraz, M.L., Perez, R.M., Lanzoni, V.P., Fi- gueiredo, V.M. and Silva, A.E. (2004) Role of gamma- glutamyl transferase activity in patients with chronic he- patitis C virus infection. Journal of Gastroenterology and Hepatology, 19, 314-318. doi:10.1111/j.1440-1746.2003.03256.x
[18] Miyoshi, E., Mo-riwaki, K. and Nakagawa, T. (2008) Bio- logical function of fucosylation in cancer biology. Jour- nal of Biochemistry, 143, 725-729.
[19] Comunale, M.A., Lowman, M., Long, R.E., Krakover, J., Philip, R., Seeholzer, S., Evans, A.A., Hann, H.W., Block, T.M. and Mehta, A.S. (2006) Proteomic analysis of se- rum associated fucosylated glycoproteins in the develop- ment of primary hepatocellular carcinoma. Journal of Pro- teome Research, 5, 308-315. doi:10.1021/pr050328x
[20] Miyoshi, E. and Nakano, M. (2008) Fucosylated hap- toglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics, 8, 3257-3262. doi:10.1002/pmic.200800046
[21] Breborowicz, J., Mackie-wicz, A. and Breborowicz, D. (1981) Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scandinavian Journal of Immunology, 14, 15-20. doi:10.1111/j.1365-3083.1981.tb00179.x
[22] Naitoh, A., Aoyagi, Y. and Asakura, H. (1999) Highly enhanced fucosyla-tion of serum glycoproteins in patients with hepatocellular car-cinoma. Journal of Gastroenter ology and Hepatology, 14, 436-445. doi:10.1046/j.1440-1746.1999.01882.x
[23] Fang, M., Zhao, Y.P., Zhou, F.G., Lu, L.G., Qi, P., Wang, H., Zhou, K., Sun, S.H., Chen, C.Y. and Gao, C.F. (2010) N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepa-tocellular carcinoma. International Journal of Cancer, 127, 148-159. doi:10.1002/ijc.25030
[24] Gui, H.L., Gao, C.F., Wang, H., Liu, X.E., Xie, Q., Dewaele, S., Wang, L., Zhuang, H., Contreras, R., Libert, C. and Chen, C. (2010) Altered serum N-glycomics in chro- nic hepatitis B patients. Liver International, 30, 259-267. doi:10.1111/j.1478-3231.2009.02170.x
[25] Nakagawa, T., Uozumi, N., Nakano, M., Mizuno-Hori- kawa, Y., Okuyama, N., Taguchi, T., Gu, J., Kondo, A., Taniguchi, N. and Miyoshi, E. (2006) Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. The Journal of Biological Chemistry, 281, 29797-29806. doi:10.1074/jbc.M605697200
[26] Noda, K., Miyoshi, E., Gu, J., Gao, C.X., Nakahara, S., Kitada, T., Honke, K., Suzuki, K., Yoshihara, H., Yoshi- kawa, K., Kawano, K., Tonetti, M., Ka-sahara, A., Hori, M., Hayashi, N. and Taniguchi, N. (2003) Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosy- lation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Research, 63, 6282-6289.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.